1
|
Myers JM, Sullivan JM. Enhanced hammerhead ribozyme turnover rates: Reevaluating therapeutic space for small catalytic RNAs. MOLECULAR THERAPY. NUCLEIC ACIDS 2025; 36:102431. [PMID: 40034206 PMCID: PMC11875169 DOI: 10.1016/j.omtn.2024.102431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/17/2023] [Accepted: 12/18/2024] [Indexed: 03/05/2025]
Abstract
We discovered enhanced hammerhead ribozyme (EhhRz) kinetic performance during therapeutic optimization of a lead agent against the human rhodopsin mRNA target. Turnover activity in trans was greater than 300 nMmin-1 under 10-fold substrate excess and physiological Mg2+ (1 mM). We validated a moderate-throughput fluorescence quantitative hhRz kinetic assay, which is linear with substrate and product moles. The EhhRz targets a CUC↓ cleavage site in a substrate with no predicted secondary/tertiary structure and demonstrates classical Michaelis-Menten turnover behavior with efficiency (V max/K m ) up to 3.2 × 106 min-1M-1. EhhRzs show cooperative Mg2+ titration (K Mg1/2 = 0.7 ± 0.02 mM; Hill = 1.7 ± 0.1). Structure-function assays showed that the upstream EhhRz antisense flank (substrate bound) interacts with stem-loop II. Tetraloop sequence variation reveals a marked effect on turnover rate. Downstream substrate U7 is not essential for enhanced activity. Single-turnover reaction rates show substantial improvements in hhRz rates at physiological Mg2+. Embedded within a target-reporter fusion mRNA, EhhRzs cleave regional target elements under intracellular conditions promoting strong knockdown at target mRNA and protein levels. EhhRzs have potential as druggable nucleic acid therapeutics against arbitrary targets, or in the design of improved aptazymes.
Collapse
Affiliation(s)
- Jason M. Myers
- Research Service, VA Western NY Healthcare System, Buffalo, NY 14215, USA
- Department of Ophthalmology (Ross Eye Institute), Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14209, USA
| | - Jack M. Sullivan
- Research Service, VA Western NY Healthcare System, Buffalo, NY 14215, USA
- Department of Ophthalmology (Ross Eye Institute), Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14209, USA
- Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14209, USA
- Department of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14209, USA
- Neuroscience Program, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14209, USA
- RNA Institute, State University of New York at Albany, Albany, NY 12222, USA
| |
Collapse
|
2
|
Singh N, Ranjan P, Cao W, Patel J, Gangappa S, Davidson BA, Sullivan JM, Prasad PN, Knight PR, Sambhara S. A Dual-Functioning 5'-PPP-NS1shRNA that Activates a RIG-I Antiviral Pathway and Suppresses Influenza NS1. MOLECULAR THERAPY. NUCLEIC ACIDS 2020; 19:1413-1422. [PMID: 32160710 PMCID: PMC7049568 DOI: 10.1016/j.omtn.2020.01.025] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/02/2019] [Accepted: 01/19/2020] [Indexed: 12/25/2022]
Abstract
Retinoic acid-inducible gene-I (RIG-I) is a cytosolic pathogen sensor that is crucial against a number of viral infections. Many viruses have evolved to inhibit pathogen sensors to suppress host innate immune responses. In the case of influenza, nonstructural protein 1 (NS1) suppresses RIG-I function, leading to viral replication, morbidity, and mortality. We show that silencing NS1 with in-vitro-transcribed 5'-triphosphate containing NS1 short hairpin RNA (shRNA) (5'-PPP-NS1shRNA), designed using the conserved region of a number of influenza viruses, not only prevented NS1 expression but also induced RIG-I activation and type I interferon (IFN) expression, resulting in an antiviral state leading to inhibition of influenza virus replication in vitro. In addition, administration of 5'-PPP-NS1shRNA in prophylactic and therapeutic settings resulted in significant inhibition of viral replication following viral challenge in vivo in mice with corresponding increases of RIG-I, IFN-β, and IFN-λ, as well as a decrease in NS1 expression.
Collapse
Affiliation(s)
- Neetu Singh
- Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
| | - Priya Ranjan
- Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
| | - Weiping Cao
- Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
| | - Jenish Patel
- Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
| | - Shivaprakash Gangappa
- Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA
| | - Bruce A Davidson
- Department of Anesthesiology, State University of New York at Buffalo, Buffalo, NY 14203, USA; Department of Pathology and Anatomical Sciences, State University of New York at Buffalo, Buffalo, NY 14203, USA; Veterans Administration Western New York Healthcare System, Buffalo, NY 14215, USA
| | - John M Sullivan
- Department of Ophthalmology, State University of New York at Buffalo, Buffalo, NY 14203, USA; Veterans Administration Western New York Healthcare System, Buffalo, NY 14215, USA
| | - Paras N Prasad
- Department of Chemistry, State University of New York at Buffalo, Buffalo, NY 14203, USA; Institute for Laser, Photonics, and Biophotonics, State University of New York at Buffalo, Buffalo, NY 14203, USA
| | - Paul R Knight
- Department of Anesthesiology, State University of New York at Buffalo, Buffalo, NY 14203, USA.
| | - Suryaprakash Sambhara
- Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329, USA.
| |
Collapse
|